Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Jorien van der Schaft
ResearcherPublications, citations & collaboration network
Jorien van der Schaft is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 40 works, 1,590 citations, an h-index of 19 and an i10-index of 24.
40
Works
1,590
Citations
19
h-index
24
i10-index
IDs:OpenAlex
How has Jorien van der Schaft's publication output changed over time?
ScholarIQpublication output · 2013–2020
Output grew200% over the shown period — from 1 works in 2013 to 3 in 2020.
1
1
1
1
3
3
201320152017201820192020
What are the most-cited papers on Jorien van der Schaft?
ScholarIQmost cited works
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Eric L. Simpson, Marjolein de Bruin‐Weller, Carsten Flohr, Michael R. Ardern‐Jones, S. Barbarot, Mette Deleuran, Thomas Bieber, Christian Vestergaard, Sara Brown, Michael J. Cork, Aaron M. Drucker, Lawrence F. Eichenfield, R. Foelster‐Holst, Emma Guttman‐Yassky, Audrey Nosbaum, Nick J. Reynolds, Jonathan I. Silverberg, Jochen Schmitt, Marieke M.B. Seyger, Phyllis I. Spuls, Jean-Francois Stalder, John Su, Roberto Takaoka, Claudia Traidl‐Hoffmann, Jacob P. Thyssen, Jorien van der Schaft, Andreas Wollenberg, Alan D. Irvine, Amy S. Paller
S58727509. 2017237 CitationsOPEN ACCESS
The association between vitamin D and cognition: A systematic review
Jorien van der Schaft, Huiberdina L. Koek, Esmée A. Dijkstra, H. J. J. Verhaar, Yvonne T. van der Schouw, Mariëlle H. Emmelot‐Vonk
Ageing Research Reviews. 2013156 Citations
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
Daphne S. Bakker, Lieneke F.M. Ariëns, C. van Luijk, Jorien van der Schaft, Judith L. Thijs, Marie L. A. Schuttelaar, Femke van Wijk, Edward F. Knol, Deepak M.W. Balak, Marijke R. van Dijk, Marjolein de Bruin‐Weller
British Journal of Dermatology. 2018154 CitationsOPEN ACCESS
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker, Deepak M.W. Balak, Margreet L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia C. A. van Amerongen, Evelien M. Delemarre, Edward F. Knol, Femke van Wijk, Stefan Nierkens, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller
Allergy. 2019150 CitationsOPEN ACCESS
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Daphne S. Bakker, Stefan Nierkens, Edward F. Knol, Barbara Giovannone, Eveline M. Delemarre, Jorien van der Schaft, Femke van Wijk, Marjolein de Bruin‐Weller, Julia Drylewicz, Judith L. Thijs
Journal of Allergy and Clinical Immunology. 2020124 CitationsOPEN ACCESS
Related on ScholarIQ
University Medical Center Utrecht
Institution
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Paper
The association between vitamin D and cognition: A systematic review
Paper
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
Paper
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Paper
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Paper